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We have read with great interest the article by Rocco et al. [1]
reporting right-sided post-pneumonectomy empyema manage-
ment in 3 cases by open-window thoracostomy and the subse-
quent application of the vacuum-assisted closure device (VAC).
Remarkably, the intrathoracic VAC therapy was performed in an
outpatient setting with bedside changes of the wound dressing
every 3 days. The authors describe that VAC therapy was efﬁcient
in draining the post-pneumonectomy space and helped obliter-
ate it. No information is given about the treatment’s efﬁciency in
healing broncho-pleural ﬁstula. However, in their experience,
VAC therapy was discontinued in 2 of the 3 patients because of
the development of severe side-effects including hypotension
and intolerable chest pain. Also, in 1 patient, the VAC foam was
entrapped by granulation tissue and its removal was considered
difﬁcult through the narrow thoracostomy.
We have recently published a series of 27 consecutive patients
who underwent intrathoracic VAC therapy for the management
of severe intrathoracic infections, including post-resection
empyema with or without broncho-pleural ﬁstula [2]. In our ex-
perience, the intrathoracic VAC treatment was well tolerated by
these high-risk patients; in particular, we did not observe
haemodynamic impairment or difﬁculties of pain control. VAC
treatment was completed in all patients and allowed for efﬁcient
control of intrathoracic infection and closure of broncho-pleural
ﬁstula when present. Our more favourable experience applying
negative pressure wound therapy in these patients may be
explained by a difference in our technical approach: in case of
broncho-pleural ﬁstula, the bronchial stump is debrided and
closed by a pediculated muscle transposed into the chest cavity.
The intrathoracic VAC dressing is then applied as an adjunct to
surgery for efﬁcient drainage, and accelerated obliteration of the
chest cavity. In contrast to Rocco et al., we feel more comfort-
able keeping these critically ill patients in the hospital during the
course of VAC therapy and performing the successive VAC dress-
ing changes under a short general anaesthesia. This is convenient
for both the patient and the surgeon as the procedure is painless
and efﬁcient. General anaesthesia allows for accurate inspection
of the chest cavity, debridement if necessary and easy replace-
ment of the VAC foam. Another advantage is that an open-
window thoracostomy is not required, since the intrathoracic
VAC dressing can be accessed by repeated opening of the thora-
cotomy. Standard perioperative monitoring also permits the as-
sessment and immediate correction of potential haemodynamic
changes while packing the cavity. Once the infection is con-
trolled and granulation tissue is abundant throughout the cavity,
the residual space, if present, is ﬁlled with an antibiotic solution
and ﬁnal chest closure is performed. In our published series,
none of the patients required chest wall reconstruction proce-
dures as no open-window thoracostomies had been performed.
The median length of VAC therapy was 22 days and the median
number of VAC changes per patient was 6.
We concluded from our experience that the intrathoracic VAC
therapy is a safe, well tolerated and effective treatment for the
management of severe intrathoracic infections. In our opinion, it
should be considered in selected patients as an alternative to
open-window thoracostomy. The major advantages are the pre-
served integrity of the chest wall and a short and efﬁcient treat-
ment course, considerably affecting patients’ satisfaction.
However, we would not recommend this approach for bedside
dressing changes in an outpatient setting.
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